These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 27593259)

  • 1. A Review on Glycosylated Hemoglobin in Polycystic Ovary Syndrome.
    Rezaee M; Asadi N; Pouralborz Y; Ghodrat M; Habibi S
    J Pediatr Adolesc Gynecol; 2016 Dec; 29(6):562-566. PubMed ID: 27593259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of glucose metabolism in polycystic ovary syndrome: HbA1c or fasting glucose compared with the oral glucose tolerance test as a screening method.
    Lerchbaum E; Schwetz V; Giuliani A; Obermayer-Pietsch B
    Hum Reprod; 2013 Sep; 28(9):2537-44. PubMed ID: 23756702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of diabetes mellitus and insulin resistance screening methods for women with polycystic ovary syndrome.
    Hurd WW; Abdel-Rahman MY; Ismail SA; Abdellah MA; Schmotzer CL; Sood A
    Fertil Steril; 2011 Oct; 96(4):1043-7. PubMed ID: 21813121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemoglobin A1c as a tool for the diagnosis of type 2 diabetes in 208 premenopausal women with polycystic ovary syndrome.
    Velling Magnussen L; Mumm H; Andersen M; Glintborg D
    Fertil Steril; 2011 Nov; 96(5):1275-80. PubMed ID: 21982282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case-control observational study of insulin resistance and metabolic syndrome among the four phenotypes of polycystic ovary syndrome based on Rotterdam criteria.
    Jamil AS; Alalaf SK; Al-Tawil NG; Al-Shawaf T
    Reprod Health; 2015 Jan; 12():7. PubMed ID: 25595199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is glycated hemoglobin related to other dysmetabolic variables implicated in the increase of cardiovascular risk in polycystic ovary syndrome? A comparative study.
    de Medeiros SF; Barbosa JS; de Medeiros MA; da Silva EB; de Souza AC; Yamamoto MM
    Exp Clin Endocrinol Diabetes; 2014 Oct; 122(9):553-7. PubMed ID: 24918529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic accuracy of oral glucose tolerance tests, fasting plasma glucose and haemoglobin A1c for type 2 diabetes in women with polycystic ovary syndrome: A systematic review and meta-analysis.
    Belsti Y; Enticott J; Azumah R; Tay CT; Moran L; Ma RCW; Joham AE; Laven J; Teede H; Mousa A
    Diabetes Metab Syndr; 2024 Mar; 18(3):102970. PubMed ID: 38442646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of insulin resistance and impaired glucose tolerance in lean women with polycystic ovary syndrome.
    Stovall DW; Bailey AP; Pastore LM
    J Womens Health (Larchmt); 2011 Jan; 20(1):37-43. PubMed ID: 21194310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homeostatic Model Assessment for Insulin Resistance (HOMA-IR): A Better Marker for Evaluating Insulin Resistance Than Fasting Insulin in Women with Polycystic Ovarian Syndrome.
    Majid H; Masood Q; Khan AH
    J Coll Physicians Surg Pak; 2017 Mar; 27(3):123-126. PubMed ID: 28406767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum fibrinogen-like protein 1 as a novel biomarker in polycystic ovary syndrome: a case-control study.
    Zhang Y; Dilimulati D; Chen D; Cai M; You H; Sun H; Gao X; Shao X; Zhang M; Qu S
    J Endocrinol Invest; 2022 Nov; 45(11):2123-2130. PubMed ID: 35790683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asymmetrical dimethylarginine, inflammatory and metabolic parameters in women with polycystic ovary syndrome before and after metformin treatment.
    Heutling D; Schulz H; Nickel I; Kleinstein J; Kaltwasser P; Westphal S; Mittermayer F; Wolzt M; Krzyzanowska K; Randeva H; Schernthaner G; Lehnert H
    J Clin Endocrinol Metab; 2008 Jan; 93(1):82-90. PubMed ID: 17986642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges.
    Jeanes YM; Reeves S
    Nutr Res Rev; 2017 Jun; 30(1):97-105. PubMed ID: 28222828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysglycemia screening with oral glucose tolerance test in adolescents with polycystic ovary syndrome and relationship with obesity.
    Gupta J; Antal Z; Mauer E; Gerber LM; An A; Censani M
    BMC Endocr Disord; 2022 Jul; 22(1):180. PubMed ID: 35842601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of impaired glucose tolerance prevalence with hemoglobin A₁c and oral glucose tolerance test in 252 Turkish women with polycystic ovary syndrome: a prospective, controlled study.
    Celik C; Abali R; Bastu E; Tasdemir N; Tasdemir UG; Gul A
    Hum Reprod; 2013 Apr; 28(4):1062-8. PubMed ID: 23335611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of hemoglobin-A1C in nondiabetic women with polycystic ovary syndrome.
    Mortada R; Comerford K; Kallail KJ; Karakas SE
    Endocr Pract; 2013; 19(2):284-9. PubMed ID: 23529348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin resistance according to β-cell function in women with polycystic ovary syndrome and normal glucose tolerance.
    Song DK; Hong YS; Sung YA; Lee H
    PLoS One; 2017; 12(5):e0178120. PubMed ID: 28542421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between circulating zinc-α2-glycoprotein levels and the different phenotypes of polycystic ovary syndrome.
    Tang C; Li X; Tang S; Wang Y; Tan X
    Endocr J; 2020 Mar; 67(3):249-255. PubMed ID: 31748429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
    Yildiz BO; Yarali H; Oguz H; Bayraktar M
    J Clin Endocrinol Metab; 2003 May; 88(5):2031-6. PubMed ID: 12727950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.